Table 7.
Heart rate (bpm) |
Respiratory rate (breaths/min) |
SPO2 (%) |
||||
---|---|---|---|---|---|---|
Proposed >95 | Existing >100 | Proposed >21 | Existing >20 | Proposed <86% | Existing nil | |
Sensitivity | 0.66 | 0.49 | 0.83 | 0.83 | 0.82 | |
(59.9–72.0) | (78.1–87.8) | (77.0–86.9) | ||||
Specificity | 0.94 | 1.0 | 0.95 | 0.83 | 0.93 | |
(90.9–97.0) | (92.2–97.7) | (89.7–96.2) | ||||
Positive predictive valuea | 0.92 | 1.0 | 0.94 | 0.83 | 0.92 | |
(88.5–95.4) | (90.9–97.0) | (88.5–95.4) | ||||
Negative predictive valuea | 0.74 | 0.66 | 0.84 | 0.83 | 0.83 | |
(68.3–79.6) | (79.3–88.6) | (78.1–87.8) |
A heart rate of greater than 100 bpm and a respiratory rate of greater than 20 breaths/min have been used to define ‘tachycardia’ and ‘tachypnoea’ for the existing LL criteria. Values in brackets indicate 95% confidence limits.
Valid for a disease prevalence as evident in the given study population.